Pacira BioSciences, Inc. logo PCRX - Pacira BioSciences, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 15
HOLD 17
SELL 4
STRONG
SELL
0
| PRICE TARGET: $29.50 DETAILS
HIGH: $32.00
LOW: $27.00
MEDIAN: $29.50
CONSENSUS: $29.50
UPSIDE: 26.34%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue
Revenue 726.4 701.0 675.0 666.8 541.5 429.6 421.0 337.3 286.6 276.4 249.0 197.7 85.6 39.1 15.7 14.6 15.0 13.9
Cost of Revenue 149.7 170.4 184.7 199.3 140.3 117.3 106.7 86.8 87.9 110.1 71.8 77.4 54.8 32.1 16.7 12.3 12.3 17.5
Gross Profit 576.7 530.5 490.3 467.5 401.3 312.3 314.3 250.4 198.7 166.3 177.2 120.2 30.8 6.9 (1.1) 2.3 2.7 (3.5)
Operating Expenses
R&D Expenses 117.3 81.6 76.3 84.8 55.5 59.4 72.1 55.7 57.3 45.7 28.7 18.7 21.6 9.9 14.9 18.6 26.2 33.2
SG&A Expenses 368.8 294.1 269.4 254.5 199.3 193.5 200.8 177.3 161.5 152.6 139.0 106.7 62.5 46.3 20.2 6.0 5.0 8.6
Other Expenses 57.3 228.2 56.9 68.2 56.5 13.0 30.9 (0.9) 0.2 (0.1) (0.2) (0.2) (0.0) (0.1) 0 0 0 0
Operating Expenses 543.4 603.9 402.6 407.5 311.4 266.0 303.8 233.0 218.8 198.3 167.7 125.4 84.1 56.2 35.0 24.7 31.3 41.8
Operating Income
Operating Income 33.3 (73.4) 87.7 60.0 89.9 46.4 10.5 15.9 (24.9) (32.0) 9.5 (5.2) (53.3) (49.3) (39.1) (22.4) (28.5) (45.4)
Interest Expense 14.6 16.6 17.3 35.6 29.0 25.7 23.6 21.9 18.0 7.1 7.7 8.3 7.3 1.8 4.8 4.9 3.6 3.5
Interest Income 22.7 19.7 11.4 4.5 0.9 4.6 7.4 6.5 4.1 1.3 0.7 0.4 0.3 0.3 0.3 0.1 0.1 0.2
Profitability
EBITDA 122.5 29.1 154.6 140.4 113.9 63.5 30.7 33.1 (10.6) (17.9) 21.4 5.1 (50.7) (44.5) (34.2) (19.1) (24.1) (41.5)
EBIT 31.5 (49.7) 79.0 48.9 85.4 43.6 11.2 19.9 (25.8) (31.4) 9.5 (5.9) (56.5) (50.5) (38.5) (22.3) (28.5) (45.4)
Income Before Tax 16.9 (63.1) 61.7 13.3 56.4 20.1 (10.7) (0.4) (42.5) (37.8) 2.1 (13.5) (64.4) (52.3) (43.3) (27.1) (28.2) (45.6)
Income Tax Expense 9.8 36.5 19.7 (2.6) 14.4 (125.4) 0.3 0.0 0.1 0.1 0.3 0.2 (0.4) 0 0 0 3.2 (3.5)
Net Income 7.0 (99.6) 42.0 15.9 42.0 145.5 (11.0) (0.5) (42.6) (37.9) 1.9 (13.7) (63.9) (52.3) (43.3) (27.1) (31.7) (41.9)
Per Share Data
EPS (Basic) 0.16 -2.15 0.91 0.35 0.95 3.41 -0.27 -0.01 -1.07 -1.02 0.05 -0.39 -1.93 -1.72 -2.64 -1.58 -55.32 -79.23
EPS (Diluted) 0.16 -2.15 0.89 0.34 0.92 3.33 -0.27 -0.01 -1.07 -1.02 0.04 -0.39 -1.93 -1.72 -2.64 -1.58 -55.32 -79.23
Shares Outstanding 44.6 46.2 46.2 45.5 44.3 42.7 41.5 40.9 39.8 37.2 36.5 35.2 33.1 30.3 16.4 17.2 0.6 0.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 158.5 276.8 153.3 104.1 585.6 100.0 78.2 132.5 54.1 35.9 7.1 12.4
Short-Term Investments 79.9 207.8 125.3 184.5 70.8 421.7 213.7 250.9 257.2 136.7 0 0
Net Receivables 124.1 113.3 105.6 98.4 96.3 53.0 47.5 38 31.7 29.9 1.5 2.6
Inventory 152.9 125.3 104.4 96.1 98.5 64.7 58.3 48.6 41.4 31.3 1.7 2.0
Other Current Assets 32.6 21.9 21.5 15.2 0 0 0 7.9 6.7 9.3 1.2 1.2
Total Current Assets 548.0 745.1 510.0 498.3 866.0 651.6 408.6 478.0 391.1 243.1 12.5 19.4
Non-Current Assets
Property, Plant & Equipment 182.5 216.4 234.9 254.4 264.8 211.2 142.8 108.7 107.0 101.0 19.6 18.0
Goodwill 20.2 0 163.2 163.2 145.2 99.5 99.5 62.0 55.2 46.7 0 0
Intangible Assets 368.1 426.0 483.3 540.5 624.0 96.5 104.4 0 0 0 11.2 13.1
Long-Term Investments 0 29.4 2.4 37.2 0 95.5 64.8 40.0 74.2 0 0 0
Other Non-Current Assets 22.3 6.2 36.0 27.2 22.0 14.0 11.0 0.7 0.8 0.6 0.7 0.1
Total Non-Current Assets 716.9 808.4 1,064.4 1,182.9 1,209.3 622.9 422.5 211.4 237.3 148.4 31.4 31.2
Total Assets 1,264.9 1,553.5 1,574.4 1,681.2 2,075.4 1,274.5 831.1 689.4 628.4 391.5 44.0 50.5
Current Liabilities
Account Payables 15.2 19.1 15.7 15.2 10.5 10.4 12.8 14.4 14.7 7.5 7.0 11.8
Short-Term Debt 9.8 201.8 8.6 33.6 374.7 149.6 0 0.3 0.3 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0.1 0.6 2.3 2.0
Other Current Liabilities 95.6 28.8 42.6 26.2 45.5 36.9 40.4 1.6 28.8 25.4 1.6 1.4
Total Current Liabilities 120.6 309.9 97.4 147.8 521.1 253.3 107.7 60.7 56.2 44.8 14.4 17.0
Non-Current Liabilities
Long-Term Debt 408.4 383.5 513.8 655.8 674.5 313.0 306.0 290.6 276.2 108.7 0 0
Deferred Tax Liabilities 4.2 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 2.5 37.1 38.3 37.8 67.4 17.4 21.5 16.9 16.5 11.4 30.9 8.3
Total Non-Current Liabilities 451.2 465.2 606.9 758.4 823.8 401.5 368.4 307.5 292.7 127.7 52.5 26.0
Total Liabilities 571.8 775.2 704.3 906.2 1,344.9 654.8 476.1 368.1 348.9 172.5 66.9 43.1
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (199.3) (206.4) (106.8) (148.8) (211.9) (253.9) (399.4) (388.2) (389.1) (346.2) (109.8) (78.1)
Accumulated Other Comprehensive Income 4.3 0.3 0.2 (0.4) 0.2 0.3 0.3 (0.3) (0.5) (0.0) (4.6) (3.2)
Total Stockholders' Equity 693.1 778.3 870.1 775.0 730.4 619.7 354.9 321.2 279.5 219.0 (22.9) 7.5
Total Liabilities & Equity 1,264.9 1,553.5 1,574.4 1,681.2 2,075.4 1,274.5 831.1 689.4 628.4 391.5 44.0 50.5
Debt Metrics
Total Debt 454.4 638.9 586.0 763.4 1,128.8 541.1 351.9 290.9 276.5 108.7 0 0
Net Debt 295.8 362.1 432.7 659.3 543.3 441.2 273.7 158.4 222.4 72.8 (7.1) (12.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 7.0 (99.6) 42.0 15.9 42.0 145.5 (11.0) (0.5) (42.6) (37.9)
Depreciation & Amortization 91.0 78.8 75.6 91.5 28.5 19.9 19.6 13.2 13.8 12.9
Stock-Based Compensation 57.5 51.2 47.9 48.1 42.2 39.9 33.6 31.7 31.6 31.2
Change in Working Capital (38.3) (18.5) (45.8) (16.4) (18.7) (24.4) (6.9) (10.9) (2.6) 22.3
Other Non-Cash Items 28.2 156.9 19.4 14.2 20.7 22.7 37.1 14.4 11.7 4.6
Operating Cash Flow 152.0 189.4 154.6 145.3 125.7 77.0 70.5 48.9 17.8 33.5
Investing Activities
Capital Expenditure (15.3) (10.6) (15.2) (30.1) (45.9) (37.8) (10.2) (14.5) (19.3) (24.7)
Acquisitions (16.7) 0 0 0 (420.0) 0 (119.3) (7) (15) (16)
Purchases of Investments (142.3) (252.2) (144.4) (400.7) (628.7) (547.7) (318.5) (363.3) (502.8) (192.8)
Sales/Maturities of Investments 268.9 179.6 237.1 237.6 1,077.8 307.9 319.5 405.2 321.7 171.6
Other Investing Activities 4.9 0 0 (32) (4) 0 0 0.2 (8.5) 0.1
Investing Cash Flow 99.5 (83.3) 77.5 (225.2) (20.8) (277.6) (128.5) 20.6 (223.8) (61.8)
Financing Activities
Net Debt Issuance (219.0) 76.6 (180.8) (427.7) 363.8 192.6 (0.3) 0 226.8 (0.0)
Stock Repurchased (148.3) (25) (0.1) 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (5.6) (34.3) (2.2) (1.2) 16.9 29.7 4.0 9.0 (2.6) 7.3
Financing Cash Flow (369.6) 17.4 (183.0) (401.5) 380.7 222.3 3.7 9.0 224.2 7.3
Cash Position
Net Change in Cash (118.2) 123.5 49.2 (481.4) 485.6 21.7 (54.3) 78.4 18.2 (21.0)
Cash at Beginning 276.8 153.3 104.1 585.6 100.0 78.2 132.5 54.1 35.9 57.0
Cash at End 158.5 276.8 153.3 104.1 585.6 100.0 78.2 132.5 54.1 35.9
Free Cash Flow 136.7 178.8 139.5 115.2 79.9 39.2 60.4 34.4 (1.5) 8.7
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Income Statement
Revenue 726.4 701.0 675.0 666.8 541.5 429.6 421.0 337.3 286.6 276.4 249.0 197.7 85.6 39.1 15.7 14.6 15.0 13.9
Gross Profit 576.7 530.5 490.3 467.5 401.3 312.3 314.3 250.4 198.7 166.3 177.2 120.2 30.8 6.9 (1.1) 2.3 2.7 (3.5)
Operating Income 33.3 (73.4) 87.7 60.0 89.9 46.4 10.5 15.9 (24.9) (32.0) 9.5 (5.2) (53.3) (49.3) (39.1) (22.4) (28.5) (45.4)
Net Income 7.0 (99.6) 42.0 15.9 42.0 145.5 (11.0) (0.5) (42.6) (37.9) 1.9 (13.7) (63.9) (52.3) (43.3) (27.1) (31.7) (41.9)
EPS (Diluted) 0.16 -2.15 0.89 0.34 0.92 3.33 -0.27 -0.01 -1.07 -1.02 0.04 -0.39 -1.93 -1.72 -2.64 -1.58 -55.32 -79.23
Balance Sheet
Cash & Equivalents 158.5 276.8 153.3 104.1 585.6 100.0 78.2 132.5 54.1 35.9 7.1 12.4
Total Assets 1,264.9 1,553.5 1,574.4 1,681.2 2,075.4 1,274.5 831.1 689.4 628.4 391.5 44.0 50.5
Total Debt 454.4 638.9 586.0 763.4 1,128.8 541.1 351.9 290.9 276.5 108.7 0 0
Stockholders' Equity 693.1 778.3 870.1 775.0 730.4 619.7 354.9 321.2 279.5 219.0 (22.9) 7.5
Cash Flow
Operating Cash Flow 152.0 189.4 154.6 145.3 125.7 77.0 70.5 48.9 17.8 33.5
Capital Expenditure (15.3) (10.6) (15.2) (30.1) (45.9) (37.8) (10.2) (14.5) (19.3) (24.7)
Free Cash Flow 136.7 178.8 139.5 115.2 79.9 39.2 60.4 34.4 (1.5) 8.7